ARCHIVES

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

ASCO Recognizes 15 for Leadership in Clinical Oncology, Updates Genetic Testing Recommendations

May 23, 2003

Oncologists lose money administering drugs to Medicare patients, survey finds.

January 23, 2004

Consensus conference On Cervical Cancer

January 26, 1996

SPORE Eligibility, Cost Issues Clarified In Addendum To RFA

October 25, 1991

In Brief: Eyre ACS President, Freeman President Elects, Kathleen Horsch Chairman, Davis Heads ASTRO

November 20, 1987

Vermont Cancer Center’s NCI Core Grant Renewed.

May 11, 2001